Talimogene Laherparepvec (T-VEC)
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Talimogene Laherparepvec (T-VEC) for carcinoma, squamous cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |